Segev Y - Search Results

1

Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.

Segev Y, Rosen B, Lubinski J, Gronwald J, Lynch HT, Moller P, Kim-Sing C, Ghadirian P, Karlan B, Eng C, Gilchrist D, Neuhausen SL, Eisen A, Friedman E, Euhus D, Ping S, Narod SA; Hereditary Breast Cancer Study Group. Segev Y, et al. Fam Cancer. 2015 Sep;14(3):383-91. doi: 10.1007/s10689-015-9798-8. Fam Cancer. 2015. PMID: 25838159 Free PMC article.

2

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.

Segev Y, Iqbal J, Lubinski J, Gronwald J, Lynch HT, Moller P, Ghadirian P, Rosen B, Tung N, Kim-Sing C, Foulkes WD, Neuhausen SL, Senter L, Singer CF, Karlan B, Ping S, Narod SA; Hereditary Breast Cancer Study Group. Segev Y, et al. Gynecol Oncol. 2013 Jul;130(1):127-31. doi: 10.1016/j.ygyno.2013.03.027. Epub 2013 Apr 3. Gynecol Oncol. 2013. PMID: 23562522

3

Risk factors for ovarian cancers with and without microsatellite instability.

Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Ping S, Narod SA, Schildkraut J. Segev Y, et al. Int J Gynecol Cancer. 2013 Jul;23(6):1010-5. doi: 10.1097/IGC.0b013e31829a5527. Int J Gynecol Cancer. 2013. Retraction in: Int J Gynecol Cancer. 2014 Sep;24(7):1356. doi: 10.1097/IGC.0000000000000255 PMID: 23748177 Free PMC article. Retracted.

4

Risk factors for ovarian cancers with and without microsatellite instability.

Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Sun P, Narod SA, Schildkraut J. Segev Y, et al. Int J Gynecol Cancer. 2014 May;24(4):664-9. doi: 10.1097/IGC.0000000000000134. Int J Gynecol Cancer. 2014. PMID: 24755492

5

Genetics of endometrial cancer.

Shai A, Segev Y, Narod SA. Shai A, et al. Among authors: segev y. Fam Cancer. 2014 Sep;13(3):499-505. doi: 10.1007/s10689-014-9722-7. Fam Cancer. 2014. PMID: 24838932 Review.

6

The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer.

Rosen B, Laframboise S, Ferguson S, Dodge J, Bernardini M, Murphy J, Segev Y, Sun P, Narod SA. Rosen B, et al. Among authors: segev y. Gynecol Oncol. 2014 Sep;134(3):462-7. doi: 10.1016/j.ygyno.2014.07.004. Epub 2014 Jul 12. Gynecol Oncol. 2014. PMID: 25026637

7

Survival in women with ovarian cancer with and without microsatellite instability.

Segev Y, Zhang S, Akbari MR, Sun P, Sellers TA, McLaughlin J, Risch HA, Rosen B, Shaw P, Schildkraut J, Narod SA, Pal T. Segev Y, et al. Eur J Gynaecol Oncol. 2015;36(6):681-4. Eur J Gynaecol Oncol. 2015. PMID: 26775351

8

Low-grade serous ovarian cancer: A review.

Kaldawy A, Segev Y, Lavie O, Auslender R, Sopik V, Narod SA. Kaldawy A, et al. Among authors: segev y. Gynecol Oncol. 2016 Nov;143(2):433-438. doi: 10.1016/j.ygyno.2016.08.320. Epub 2016 Aug 28. Gynecol Oncol. 2016. PMID: 27581327 Review.

9

Impact of BRCA mutations on outcomes among patients with serous endometrial cancer.

Kadan Y, Raviv O, Segev Y, Lavie O, Bruchim I, Fishman A, Michaelson R, Beller U, Helpman L. Kadan Y, et al. Among authors: segev y. Int J Gynaecol Obstet. 2018 Jul;142(1):91-96. doi: 10.1002/ijgo.12486. Epub 2018 Apr 2. Int J Gynaecol Obstet. 2018. PMID: 29572834

10

Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1/2 mutated patients- a systematic review and meta-analysis.

Nahshon C, Segev Y, Gemer O, Bar Noy T, Schmidt M, Ostrovsky L, Lavie O. Nahshon C, et al. Among authors: segev y. Gynecol Oncol. 2021 Mar;160(3):755-762. doi: 10.1016/j.ygyno.2020.11.034. Epub 2020 Dec 10. Gynecol Oncol. 2021. PMID: 33309051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters